JIP
HQL

Jaffetilchin Investment Partners’s abrdn Life Sciences Investors HQL Stock Holding History

Jaffetilchin Investment Partners’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,585
Closed -$69.1K – 771
2024
Q3 		$69.1K Buy
+4,585
New +$69.4K 0.01% 525

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Jaffetilchin Investment Partners's HQL Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of abrdn Life Sciences Investors (HQL) in Q4 2024, closing a stake of 4,585 shares — an estimated $69.1K sold.

Jaffetilchin Investment Partners first reported a position in HQL in Q3 2024 and held it in 1 quarter. The position peaked at $69.1K in Q3 2024. 72 funds tracked by Wall St. Rank hold HQL as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining abrdn Life Sciences Investors position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 4,585 abrdn Life Sciences Investors shares in Q4 2024, an estimated $69.1K.
  • Jaffetilchin Investment Partners first reported a position in abrdn Life Sciences Investors in Q3 2024 and held it in 1 quarter.
  • Jaffetilchin Investment Partners's abrdn Life Sciences Investors position peaked at $69.1K in Q3 2024.
  • 72 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.